PATENT CLAIM ANALYSIS

Application Number: 15872373
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "007920"]

Abstract:
Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.

Claim (Index 43):
The method of  claim 41 , wherein the one or more additional metabolites is cinnamoylglycine.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.9
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14763962', '14344655', '13966475', '14975988', '14324689']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6415654841721743
- 35 USC 102 Novelty (BERT): 0.5465411668106326
- Combined Prediction Score: 0.6320630524360201
- Mean Citation Score: 298.71936399999987
- Max Citation Score: 454.83432
- Similarity Product: 254.36042611895084

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test